These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15370944)

  • 1. Methamphetamine abstinence syndrome: preliminary findings.
    Newton TF; Kalechstein AD; Duran S; Vansluis N; Ling W
    Am J Addict; 2004; 13(3):248-55. PubMed ID: 15370944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nature, time course and severity of methamphetamine withdrawal.
    McGregor C; Srisurapanont M; Jittiwutikarn J; Laobhripatr S; Wongtan T; White JM
    Addiction; 2005 Sep; 100(9):1320-9. PubMed ID: 16128721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric comorbidity of methamphetamine dependence in a forensic sample.
    Kalechstein AD; Newton TF; Longshore D; Anglin MD; van Gorp WG; Gawin FH
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):480-4. PubMed ID: 11083165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal symptoms in abstinent methamphetamine-dependent subjects.
    Zorick T; Nestor L; Miotto K; Sugar C; Hellemann G; Scanlon G; Rawson R; London ED
    Addiction; 2010 Oct; 105(10):1809-18. PubMed ID: 20840201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of environmental enrichment during induction of methamphetamine dependence on the behavioral withdrawal symptoms in rats.
    Hajheidari S; Miladi-Gorji H; Bigdeli I
    Neurosci Lett; 2015 Sep; 605():39-43. PubMed ID: 26275348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the environmental enrichment on the severity of psychological dependence and voluntary methamphetamine consumption in methamphetamine withdrawn rats.
    Hajheidari S; Miladi-Gorji H; Bigdeli I
    Neurosci Lett; 2015 Jan; 584():151-5. PubMed ID: 25459292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety level and correlates in methamphetamine-dependent patients during acute withdrawal.
    Su H; Zhang J; Ren W; Xie Y; Tao J; Zhang X; He J
    Medicine (Baltimore); 2017 Apr; 96(15):e6434. PubMed ID: 28403074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine-associated difficulties in cognitive control allocation may normalize after prolonged abstinence.
    Stock AK; Rädle M; Beste C
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():41-52. PubMed ID: 29953935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake.
    Shabani S; Schmidt B; Ghimire B; Houlton SK; Hellmuth L; Mojica E; Phillips TJ
    Genes Brain Behav; 2019 Mar; 18(3):e12533. PubMed ID: 30375183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and acceptability of approach bias modification during methamphetamine withdrawal and related methamphetamine use outcomes.
    Manning V; Garfield JBB; Mroz K; Campbell SC; Piercy H; Staiger PK; Lum JAG; Lubman DI; Verdejo-Garcia A
    J Subst Abuse Treat; 2019 Nov; 106():12-18. PubMed ID: 31540606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prolonged abstinence from METH on the hippocampal BDNF levels, neuronal numbers and apoptosis in methamphetamine-sensitized rats.
    Hajheidari S; Sameni HR; Bandegi AR; Miladi-Gorji H
    Neurosci Lett; 2017 Apr; 645():80-85. PubMed ID: 28249787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes.
    Lee N; Pennay A; Hester R; McKetin R; Nielsen S; Ferris J
    Drug Alcohol Rev; 2013 Jan; 32(1):88-95. PubMed ID: 22630616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum malondialdehyde levels and depression during early methamphetamine withdrawal.
    Luan X; Chen H; Qiu H; Shen H; Zhao K; Ren W; Gu Y; Su H; Zhang J; Lv D; He J
    Neurosci Lett; 2018 Nov; 687():22-25. PubMed ID: 30219487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals.
    Newton TF; Cook IA; Kalechstein AD; Duran S; Monroy F; Ling W; Leuchter AF
    Clin Neurophysiol; 2003 Mar; 114(3):410-5. PubMed ID: 12705421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence.
    Kalechstein AD; Newton TF; Green M
    J Neuropsychiatry Clin Neurosci; 2003; 15(2):215-20. PubMed ID: 12724464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stimulative role of corticotropin-releasing factor in methamphetamine-seeking behavior induced by footshock].
    Nawata Y; Kitaichi K; Yamamoto T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Apr; 31(2):73-5. PubMed ID: 21870363
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P300 event-related potential in abstinent methamphetamine-dependent patients.
    Haifeng J; Wenxu Z; Hong C; Chuanwei L; Jiang D; Haiming S; Zhikang C; Din X; Jijun W; Min Z
    Physiol Behav; 2015 Oct; 149():142-8. PubMed ID: 26051625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder.
    Leventhal AM; Kahler CW; Ray LA; Stone K; Young D; Chelminski I; Zimmerman M
    Am J Addict; 2008; 17(3):218-23. PubMed ID: 18463999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
    Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
    Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.